Advertisement

Topics

X4 Pharmaceuticals, Yale University Announce Rare Disease Research Collaboration

14:00 EDT 4 Aug 2017 | Drug Discovery Development

The collaboration will investigate the fundamental mechanisms that result in chronic immune deficiency in a genetic preclinical model of WHIM syndrome.
Contributed Author: 
X4 Pharmaceuticals

Original Article: X4 Pharmaceuticals, Yale University Announce Rare Disease Research Collaboration

NEXT ARTICLE

More From BioPortfolio on "X4 Pharmaceuticals, Yale University Announce Rare Disease Research Collaboration"

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...